Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Liked2Thinkon Sep 21, 2022 7:09pm
148 Views
Post# 34977785

RE:I'm sure that's not a signal

RE:I'm sure that's not a signal
LithLover wrote: A $0.51 trade on a secondary market (P Exchange). Nice.

No manipulation here just a free flowing market.  


11:38:54 P 0.085   6 14 Virtu ITG 14 Virtu ITG E



10 days left in Q3. 

Cash on hand at end of June was $90,626 additional financing of $177,000.  Total max cash avaiable without any additional financing is $267,626.  Gotta assume they leave some in the bank so what a total of $200,000 cash used in Q3 or are we going to get an update on additional debentures issued?

Q2 cash used was 
$518,593.






Something has to give.  Q3 has to show an increase in revenue or how they are continuing to operate will have to be told to the investors.

The only thing we know for sure Q3 results wont be out until the very last possible day so you have another 6 weeks to wait for the results and I wonder how much "less" they will be telling shareholders now.  Sure wont get any results of how many aristotle tests were done.  Thats far too hard to track.

<< Previous
Bullboard Posts
Next >>